Prostate Specific Antigen (PSA) Measurement
Report: Task Force to Recommend Against PSA Test
The exam for prostate cancer has been controversial for some time
THURSDAY, Oct. 6 (HealthDay News) -- The U.S. Preventive Services Task Force is preparing to recommend that men no longer get screened for prostate cancer by undergoing prostate specific antigen -- or PSA -- testing, CNN reported Thursday evening, citing a "source privy to the task force deliberations."
The task force is the same group of independent medical experts that unleashed a storm of controversy in 2009 by recommending that women in their 40s didn't need regular mammograms.
According to CNN, the task force will recommend that the PSA blood test get a "D" rating, which means "there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits," according to the group's website.
CNN said the task force recommendation could come as soon as Tuesday, followed by a comment period before the group issues a final recommendation.
A draft copy of a task force report scheduled to be released Monday will say that a review of studies indicates that the PSA blood test -- which measures the presence of prostate specific antigen, a protein produced by cells of the prostate gland -- results in "small or no reduction" in prostate cancer deaths, the news network reported.
The test has been controversial for some time. Many doctors contend that the screen often uncovers tumors that are small and slow growing, and will never cause a man to die. On the other hand, treating the disease can often leave a patient impotent or incontinent.
Some prostate cancer patients were disappointed with the task force's decision.
A spokesman for the Prostate Cancer Foundation, Dan Zenka, described the proposed recommendation as "a tremendous mistake. You're talking to someone whose life was saved by [the PSA test]," CNN reported.
But Dr. Kenneth Lin, senior author of the paper due to be released Monday, said he believes PSA testing does more harm than good, the news network reported.
"Maybe you should get tested if you have this horrible family history where everyone gets prostate cancer before the age of 50. But for most men, testing is harmful," he said.
The U.S. Preventive Services Task Force is an independent panel of experts in prevention and evidence-based medicine and consists of primary care doctors, such as internists, pediatricians, family physicians, gynecologists/obstetricians, nurses, and health behavior specialists, according to the organization's website.
The task force conducts scientific evidence reviews of a broad range of clinical preventive health care services (such as screening, counseling, and preventive medications) and develops recommendations for primary care clinicians and health systems.
According to the American Cancer Society, prostate cancer is the most common type of cancer found in American men, other than skin cancer. It's the second leading cause of cancer death in men, behind only lung cancer.
The cancer society estimates that there are approximately 240,890 new cases of prostate cancer diagnosed each year, and about 34,000 men die from the disease annually.
To learn more, visit the American Cancer Society.